Cure My Disease

Don't miss your cure!

 Log in / Sign up

Immune system clues may predict infections in ICU patients

NCT ID NCT06511622

Completed Knowledge-focused Sponsor: Charite University, Berlin, Germany Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at 686 patients with acute respiratory distress syndrome (ARDS) to see how their immune status affects the risk of secondary infections like herpes or cytomegalovirus. Researchers measured immune cells and virus reactivation in blood and lung samples. The goal is to better understand which patients are most vulnerable, potentially guiding future prevention strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors identify ARDS patients at higher risk for secondary infections, leading to better monitoring or preventive care.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove cause and effect, and findings may not apply to all ARDS patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARDS

Contacts and locations

Locations

  • Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Charité - University Medicine Berlin

    Berlin, 10117, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.